Skip to main content

Peer Review reports

From: Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone

Original Submission
13 May 2021 Submitted Original manuscript
2 Jun 2021 Reviewed Reviewer Report
3 Jun 2021 Reviewed Reviewer Report
4 Jun 2021 Reviewed Reviewer Report
21 Jun 2021 Author responded Author comments - Yonghong Li
Resubmission - Version 2
21 Jun 2021 Submitted Manuscript version 2
Publishing
5 Aug 2021 Editorially accepted
13 Aug 2021 Article published 10.1186/s12885-021-08670-2

You can find further information about peer review here.

Back to article page